# Evaluation of the Tolerance (Main Objective) and Performance of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots (Solar and Senile Lentigines, Post-inflammatory Hyperpigmentation) on the Face

> **NCT06305897** · NA · UNKNOWN · sponsor: **Cryonove Pharma** · enrollment: 45 (estimated)

## Conditions studied

- Lentigo
- Solar Lentigo
- Post Inflammatory Hyperpigmentation

## Interventions

- **DEVICE:** CRYONOVE (EC14_4osc)
- **DEVICE:** CRYONOVE (EC+05_1osc)
- **DEVICE:** CRYONOVE (EC+05_2osc)

## Key facts

- **NCT ID:** NCT06305897
- **Lead sponsor:** Cryonove Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-04
- **Primary completion:** 2024-12
- **Final completion:** 2024-12
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2024-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06305897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06305897, "Evaluation of the Tolerance (Main Objective) and Performance of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots (Solar and Senile Lentigines, Post-inflammatory Hyperpigmentation) on the Face". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06305897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*